Assessing the external validity of model-based estimates of the incidence of heart attack in England: a modelling study by unknown
RESEARCH ARTICLE Open Access
Assessing the external validity of model-
based estimates of the incidence of heart
attack in England: a modelling study
Peter Scarborough1*, Kate Smolina2, Anja Mizdrak1, Linda Cobiac3 and Adam Briggs1
Abstract
Background: The DisMod II model is designed to estimate epidemiological parameters on diseases where
measured data are incomplete and has been used to provide estimates of disease incidence for the Global Burden
of Disease study. We assessed the external validity of the DisMod II model by comparing modelled estimates of the
incidence of first acute myocardial infarction (AMI) in England in 2010 with estimates derived from a linked dataset
of hospital records and death certificates.
Methods: Inputs for DisMod II were prevalence rates of ever having had an AMI taken from a population health
survey, total mortality rates and AMI mortality rates taken from death certificates. By definition, remission rates were
zero. We estimated first AMI incidence in an external dataset from England in 2010 using a linked dataset including
all hospital admissions and death certificates since 1998. 95 % confidence intervals were derived around estimates
from the external dataset and DisMod II estimates based on sampling variance and reported uncertainty in
prevalence estimates respectively.
Results: Estimates of the incidence rate for the whole population were higher in the DisMod II results than the
external dataset (+54 % for men and +26 % for women). Age-specific results showed that the DisMod II results
over-estimated incidence for all but the oldest age groups. Confidence intervals for the DisMod II and external
dataset estimates did not overlap for most age groups.
Conclusion: By comparison with AMI incidence rates in England, DisMod II did not achieve external validity for
age-specific incidence rates, but did provide global estimates of incidence that are of similar magnitude to
measured estimates. The model should be used with caution when estimating age-specific incidence rates.
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Background
For many diseases, estimates of incidence and preva-
lence are often incomplete or based on different data
sources making it difficult to compare results [1]. Reli-
able and representative population level epidemiological
data are needed to inform health care policy and to sup-
port decision making processes in health service plan-
ning and delivery, and are essential to cost effectiveness
analyses and burden of disease calculations. Due to gaps
in directly measured data, models have been established
that can estimate incidence and prevalence rates of dis-
eases. DisMod II is such a model. It uses available epi-
demiological data about a condition to estimate missing
data on incidence, prevalence, remission and case fatality
rates as applicable [2, 3]. Originally developed for the
Global Burden of Disease studies [4], DisMod II is freely
available for use and can be downloaded from http://
www.epigear.com/index.htm.
The DisMod II model is a multistate life table that fully
describes the epidemiological progress of a single disease by
exploiting the fact that parameters such as incidence, preva-
lence, remission, case fatality and mortality rates are not in-
dependent variables. By solving a set of differential
equations, Dismod II can estimate age-specific incidence,
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prevalence or case fatality rates for a disease, given suffi-
cient data on the other (for example, with input data of
age-specific prevalence, case fatality and mortality data for
a disease, Dismod II will estimate the age-specific incidence
rate for the disease). The model operates by calculating the
number of people in each of three states: healthy, diseased
and dead at any age. Within the model, there are two
causes of death, either from the disease or from ‘all other’
causes, that are assumed to be independent. There are four
transition hazards which are age specific (assumed to be
constant within a 1-year age interval): incidence, remission,
case fatality, and the “all other mortality” hazard. The input
data for the model are age and sex-specific estimates of
three out of the four parameters described above for a given
population, and a complete set of parameters (smoothed
from the original or estimated from the original parame-
ters) is the output of the model.
Ischaemic heart disease (IHD) is the most common
cause of death in the UK [5] and acute myocardial infarc-
tion (AMI) is coded on death certificates as the cause of
approximately one third of all deaths from IHD [6]. AMI
mortality and prevalence data for having had an AMI in
England are routinely collected by the Office of National
Statistics (ONS) and the Health Survey for England (HSfE)
[7] respectively. However, until recently, there have been
no published comprehensive, population-based national
level estimates of AMI incidence [8] and these recent esti-
mates are unlikely to be routinely updated. Incidence of
AMI is important to researchers and public health policy
makers because it serves as an indicator of the effective-
ness of preventative measures and management of risk
factors through health promotion and other public health
initiatives. Without a tool that allows routinely updated
estimates of incidence, measurements of the current bur-
den of AMI in England have significant limitations.
This study assesses the external validity of DisMod II es-
timates of the incidence of first AMI in England by com-
parison with estimates generated from the dataset used to
support a recent series of related papers [8–10]. Establish-
ing the external validity of the modelled estimates would
demonstrate that the DisMod II model could be used as a
tool for regularly updating estimates of the incidence of
AMI—data that are not routinely collected in England. It
would also help to establish confidence in studies of non-
communicable disease that use DisMod II to estimate in-
cidence, such as in modelling studies [11], and studies
estimating disease burden where incidence data are scarce
or not regularly updated [12, 13]. Since the 2010 iteration,
the Global Burden of Disease study [4] results have been
based on an updated (but closely related) version of the
DisMod model, which is not freely available for use. As-
sessments of the external validity of DisMod II offer in-
sights into the assumptions used for this important and
widely used global project.
Methods
Disease definitions
The exact definitions that were used in this paper for
the condition under investigation are provided in Table 1.
In this table, the model outcome that was compared
with the external datasets is prefixed with OUTCOME.
The remaining model definitions are descriptions of the
theoretical measures that are consistent with the out-
come of interest, and the corresponding external data
definitions describe where the model input data were
taken from, and how similar they are to the theoretical
measures.
Outcome measures
For AMI, measured data on prevalence, excess mortality
and remission were used to create modelled data on in-
cidence. The modelled incidence data were compared
against measured estimates from the dataset used for
similar results published in the peer reviewed literature
which were independent of all input data to the DisMod
II model [8]. The difference between the modelled and
the measured estimates was calculated and displayed for
all ages. Differences were recorded in percentages, with
the measured data as the baseline.
Data sources
Model inputs
Single-year population estimates by sex were taken from
the Office for National Statistics (ONS), for the year
2010. Mortality data where AMI was recorded as the
underlying or contributory cause of death (ICD-10 codes
I21-I22) by sex and 5 year age groups were provided by
ONS. Part of the modelling process for DisMod II is to
interpolate data into single year estimates, in order to
have smooth rates for all the consistent modelled out-
puts. For the mortality data, this was achieved using a






(data source in brackets)
Incidence OUTCOME: Incidence
of first AMI (2010)
Incidence of first AMI since 1998
(linked hospital episodes and
mortality statistics, 2010).
Prevalence Prevalence of ever
having had an AMI
(2010)
Prevalence of ever having had a
doctor-diagnosed AMI (Health





to first AMI (2010)
Death where AMI is included
anywhere on the death certificate
(ONS mortality statistics, 2010).
Abbreviations: ONS Office for National Statistics, AMI Acute
Myocardial Infarction
a Remission is zero because the prevalence data measures people who have
ever been diagnosed with AMI
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cubic spline interpolation on a log transformation of the
original data.
Age and sex-specific estimates of the prevalence of
ever having had a doctor’s diagnosis of heart attack were
taken from the Health Survey for England (HSfE) 2011
[7]. The HSfE covers all of England and is a nationally
representative sample of those residing at private resi-
dential addresses. In the 2011 survey, a sample of 8610
individuals between aged 16 and 99 was recruited, with
a household response rate of 66 %. Residents of care
homes, prisons and the homeless were excluded which
is thought to contribute to <2 % of the population.
Those who were unable to consent and those who were
unable to understand the questions or formulate answers
(due to language difficulties, disability or mental illness)
were termed non-responders. Figures 1 and 2 show the
model input data (both raw and smoothed) by age for
men and women.
External validation
A recent series of papers examined AMI incidence, case
fatality, survival, and trends in event rate, case fatality
and mortality between 2002 and 2010 in a population
based study using person linked routine hospital and
mortality data in England [8–10]. Hospital episode sta-
tistics provide information on all patients admitted to
hospital whose care is funded by the English NHS. An
AMI event was classified as an emergency hospital ad-
mission with primary diagnosis of AMI and a length of
stay of more than 1 day for someone discharged alive, or
a death with acute myocardial infarction coded as the
underlying cause of death on the death certificate. Fatal
cases were defined as those where AMI was coded as
the underlying cause of death on the death certificate or
any death that occurred within 30 days of an admission
for AMI which was assumed to relate to the same event.
Bespoke analyses using the same dataset and methods
have been used to generate measures of the incidence of
first AMI in England in 2010, which are used as the ex-
ternal comparator in these analyses. Because the linked
dataset used for these analyses only includes hospital ep-
isodes and deaths from 1998 onwards, these measures
are strictly of the incidence of first AMI since 1998 in
England in 2010 (i.e. a person who had a first heart at-
tack before 1998 and then a second heart attack in 2010
would be counted as a first heart attack in our dataset).
DisMod II settings
Prevalence, remission (set as zero), and disease specific
mortality were used as inputs in the DisMod II model.
Population numbers and mortality rates for England 2010
were also used. The prevalence and mortality data were
fitted with a sigmoid mathematical curve in order to
smooth out the data points which have relatively large age
group widths. Analyses were conducted with and without
accounting for trends in AMI incidence rates. When
trends were applied, an annual change in incidence rate of
−4 % and an annual change in case fatality of −1 % for the
previous 28 years was incorporated into the model. These
trends are based on a study of trends in CHD since 1978
[14]. For a sensitivity analysis, larger trends were also ap-
plied that were taken from an analysis of incidence and
case fatality rates over the previous 10 years in England
[9]—these were −5 % for incidence and −4 % for case-
fatality for both men and women. Application of a trend
in DisMod II assumes that each age group is changing at
the same rate as the overall trend. The DisMod II uncer-
tainty analysis was conducted to assess uncertainty around
the modelled incidence estimates. Here, DisMod II con-
ducts a parametric bootstrapping exercise, where the
Fig. 1 The data inputs used for the modelling exercise: prevalence of acute myocardial infarction by age and sex, actual data and smoothed
data. The blue lines show actual and smoothed data for men and the red lines show actual and smoothed data for women
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input data are allowed to vary according to a specified dis-
tribution. We allowed the estimates of prevalence of hav-
ing had a heart attack to vary with a normal distribution
according to the uncertainty reported in the HSfE. We did
not specify any uncertainty in either the mortality or the
remission estimates. Due to lack of computing power, it
was not possible to conduct an uncertainty analysis for
the DisMod II runs where trends were assumed.
The complete set of results and the data used to run
the DisMod II model for these analyses are available
from the authors upon request.
Results
Figures 3 and 4 show the age-specific estimates of inci-
dence of AMI for men and women separately. The green
lines show the estimates from the external dataset with
accompanying 95 % confidence intervals and the blue
lines show the estimates from DisMod II with accom-
panying 95 % credible intervals (i.e. the distance between
which 95 % of the iterations of the uncertainty analysis
fell). The red line shows the estimates from DisMod II
where trends in incidence and case fatality have been in-
corporated. The figures show that, for both men and
Fig. 2 The data inputs used for the modelling exercise: excess mortality rates for acute myocardial infarction, actual data and smoothed data. The
blue lines show actual and smoothed data for men and the red lines show actual and smoothed data for women
Fig. 3 The incidence rate per 100,000 of first acute myocardial infarction in males in England in 2010. The green lines are estimates from the
external dataset with 95 % confidence intervals. The blue lines are estimates from DisMod II with 95 % credible intervals that do not account for
trends in incidence and case fatality. The red line is the estimate from DisMod II that does account for trends in incidence and case fatality
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women, the DisMod II estimates tend to over-estimate
the incidence of AMI at younger age groups and under-
estimate for the oldest age groups (greater than 85 in
men, and greater than 75 in women). For both men and
women, for the majority of age groups the confidence
intervals between the external dataset and the DisMod II
estimates did not overlap, suggesting poor external valid-
ity of the DisMod II estimates as AMI incidence rates
increase. Applying trends in incidence and case fatality
rates to the DisMod II estimates resulted in reduced in-
cidence rates at all ages than without adjustment and an
s-shaped curve for AMI incidence in women where the
model estimated a lower incidence in women in their
70s compared to those in their 60s. The sensitivity ana-
lysis with larger trends in incidence resulted in further
reductions in the estimates of MI incidence for both
men and women, but the s-shaped curve in women did
not persist (data not shown). Table 2 shows how the
non-trended DisMod II estimates of incidence rates for
the total population produced over-estimates of the inci-
dence of MI by approximately 54 % in men and 26 % in
women, but this masks larger differences for age-specific
subgroups, including under-estimates of incidence in the
oldest age groups.
Discussion
This study assessed the external validity of DisMod II esti-
mates of the age-specific incidence rate of AMI in England
in 2010. Although the modelled estimates and the external
dataset resulted in incidence rates in the whole population
that were of similar magnitude, the age-specific rates were
not consistent with the external dataset; they over-
estimated rates in younger age groups and under-
estimated rates in the oldest age groups. Incorporating
trends in the incidence and case fatality of AMI in the
DisMod II estimates resulted in estimated and observed
AMI incidence being more closely matched at younger
age groups than without trends but with more divergent
results at older ages, including for one set of results the
implausible scenario of women in their 70s having a lower
incidence of AMI than women in their 60s. This study im-
plies that DisMod II is not an appropriate source of age-
specific estimates of the incidence of AMI for England
and future estimates should be based on measured
outcomes.
Modelled estimates of the burden of disease in differ-
ent populations are extremely important for policy
makers and health care planners. They allow for an as-
sessment of where to direct scarce resources in terms of
treatment and care, and assist in planning for future
health care requirements. They can also be used as the
basis for comparing the burden of disease that is attrib-
utable to different behavioural risk factors (e.g. the glo-
bal comparable risk assessment exercise, Global Burden
of Disease [3, 15], or modelling studies to assess the ef-
fectiveness or cost-effectiveness of public health inter-
ventions [11, 16, 17] which in turn influences how
public health resources are directed).
The DisMod II model is the most recent freely avail-
able version of the model that is used for the Global
Fig. 4 The incidence rate per 100,000 of first acute myocardial infarction in females in England in 2010. The green lines are estimates from the
external dataset with 95 % confidence intervals. The blue lines are estimates from DisMod II with 95 % credible intervals that do not account for
trends in incidence and case fatality. The red line is the estimate from DisMod II that does account for trends in incidence and case fatality
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Burden of Disease project and it is currently being used
by non-communicable disease scenario models [18]
which have been built in order to estimate the popula-
tion health impact of public health interventions. For ex-
ample, Cecchini et al. (2010) [11] used DisMod II to
estimate the incidence of various cardiovascular diseases
and risk factors when simulating the possible effects on
health of different diet and physical activity interven-
tions. Previous studies have also used DisMod II to esti-
mate disease incidence from prevalence, remission, and
disease specific mortality rates where incidence data are
scarce. For example, Johnston et al. (2009) [13] esti-
mated the global stroke burden and used DisMod II to
estimate stroke incidence from mortality and case fatal-
ity data for countries where only partial data exist. Rehm
et al. (2009) [12] used prevalence, relative risk of mortal-
ity, and remission rates to estimate the global incidence
of alcohol-use disorders.
Wherever possible, the validity of the DisMod II mod-
elled estimates should be assessed by comparison with
actual measured data from the population of interest.
This study utilised recent results estimating the inci-
dence of AMI in England using linked hospital episode
statistics and death certificates, which captures the vast
majority of incident AMIs that occur in England [9] and
as such represents a robust dataset for assessment of ex-
ternal validity. The present study complies with all of
the ‘best practices’ identified in the ISPOR modelling
guidelines for external validation studies [19].
The DisMod II software provides users with a variety of
choices about how the input data should be manipulated
before the outputs are calculated. These choices include:
the method used to interpolate input data to single year
estimates (cubic spline or polynomial methods); the shape
of the curve to fit the smoothed age-related input data
(linear, quadratic, sigmoid, simple exponent or polyno-
mial); and whether or not to allow for time trends in the
input data. These three choices alone would generate
twenty different sets of results, which we did not choose
to display—rather we chose the settings that best suited
the epidemiology of AMI. The alternative of using crude
input data was not preferable due to inherent problems
with the crude data. For example, the prevalence data
used in the analyses were taken from the Health Survey
for England [7], where rates are reported for 10 year age
groups. Using the crude data would lead to large step
changes in prevalence as age increases, which resulted in
implausible shapes to the modelled incidence data. In
practice, changing the specific selections for manipulating
the input data did not improve the comparison between
the DisMod II estimates and the external dataset. We de-
cided to report the results both for when trends in inci-
dence and case fatality were applied and when they were
not as cardiovascular disease rates are decreasing rapidly
in the UK and have been for some time [20]. This is im-
portant for the DisMod II model, as the method used for
solving the differential equations assumes a ‘steady state’
for the disease being modelled (i.e. that age-specific preva-
lence, incidence and mortality rates for the disease are
static). This allows DisMod II to assume that the preva-
lence of AMI at age t equals the prevalence of AMI at age
t-1 plus incident cases minus dying cases. But input data
are all taken from the same year (y), whereas data for age
t-1 should be taken from y-1. This is not a problem if the
data in year y-1 are equal to those in year y, but if there
are trends in the data (is the case for falling AMI inci-
dence rates), this is not the case. For AMI, the incidence
and case fatality rate trend data that we applied were taken
from the British Regional Heart Study, a cohort study car-
ried out in British men aged 40–59 at entry between 1978
and 2000 [14]. This study only examines trends in coron-
ary heart disease in men, however other studies report de-
clines of similar magnitude in both men and women [21,
22]. A sensitivity analysis which applied more recent data
that were specific to both men and women did not im-
prove the validity of the modelled results. It is not possible
to apply age-stratified trends in DisMod II and therefore
the same trends were applied across all age groups and
the analyses reported here. However, whilst overall there
has been a decline in incidence rates, this decline varies by
age with the lowest rate of decline occurring in those aged
Table 2 Number of first AMI events in England, 2010
Number Incidence rate per 100,000




DisMod IIa External Dataset DisMod IIa %
difference
Men
0–29 105 1588 1 (1, 1) 16 1412
30–54 7035 12,558 79 (77, 81) 141 79
55–64 8446 13,919 282 (276, 288) 465 65
65–74 9674 16,703 451 (442, 460) 779 73
75–84 10,451 14,147 828 (812, 844) 1121 35
85+ 5978 5487 1521 (1483, 1559) 1396 −8
Total 41,689 64,401 162 (160, 163) 250 54
Women
0–29 38 88 0 (0, 1) 1 132
30–54 1752 3091 19 (19, 20) 34 76
55–64 2573 6664 83 (79, 86) 214 159
65–74 4817 9534 205 (200, 211) 407 98
75–84 8640 8490 521 (510, 532) 512 −2
85+ 8911 5903 1107 (1084, 1130) 733 −34
Total 26,731 33,769 101 (100, 102) 128 26
aThe DisMod II results are those estimated without the application of
trend data
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85 and over [9]. Both the mis-match between the external
and modelled datasets and reported declines in AMI inci-
dence are age-specific, making this a likely candidate for
the failure of the model to produce externally valid esti-
mates of the incidence of AMI in England. However, with-
out further investigation using a model that can
incorporate age-specific trends in incidence and mortality
it is not possible to prove this assertion.
Another important limitation of our validity assess-
ment is our input data for mortality. The ideal data for
the DisMod II model would be estimates of the in-
creased all-cause mortality rate for people who have pre-
viously had a heart attack. We were unable to find direct
measures, so we used data on all deaths where AMI was
indicated as either the primary cause or a contributing
factor. This accounts for the fact that mortality rates
from AMI are higher in those that have previously had a
heart attack but may not include all increased mortality
risk for other conditions (e.g. increased risk of pneumo-
nia) [10, 23].
We found three other studies that compared outputs
from the DisMod II software with measured epidemio-
logical data. Manuel et al. (2007) [24] used AMI incidence
data from linked hospital records and death certificates data
to estimate prevalence of having had an AMI in Ontario,
Canada and compared these modelled prevalence rates
with estimates derived from a population health survey.
The DisMod estimates for both men and women were very
similar to those derived from the population health survey,
and were within the 95 % confidence intervals. However,
the authors did not report on age-specific estimates of
prevalence, so it is unclear whether the estimates from the
two sources showed similar age trajectories. Saha et al.
(2008) [25] compared estimates of prevalence and inci-
dence of schizophrenia derived from DisMod II with paired
incidence and prevalence estimates from 15 identified stud-
ies. They found that the DisMod II estimates of prevalence
were generally higher than those identified in the studies
and the estimates of incidence were generally lower, but no
age-specific modelled prevalence or incidence rates were
reported. One third of the modelled estimates were within
50 % of the estimates from the identified studies. Kruijshaar
et al. (2002) [26] compared DisMod estimates of prevalence
for breast, prostate, colorectal and stomach cancer with
cancer registry data from the Netherlands. Age-specific
prevalence estimates were similar to observed rates for
colorectal and stomach cancer, but considerably higher for
prostate and breast cancer (for some ages modelled esti-
mates were two and three times higher than measured
rates, respectively). In all three studies the authors sug-
gested that inadequate description of trends in the studied
disease limits the accuracy of the modelled estimates. Given
the findings from these studies and the results presented
here and the ongoing use of DisMod II in epidemiological
modelling studies, it is important that the external validity
of DisMod II be further examined with different disease
outcomes in different populations.
Another potential source of error in our analyses
is the accuracy of the estimates of prevalence of hav-
ing had AMI from the HSfE. Although the HSfE
series is broadly representative of the English popu-
lation, it does not include residential care home set-
tings in its sample structure. In 2011, around
260,000 people aged 75 and over lived in residential
care homes (about 6 % of this age group in England)
[27]. Since the incidence rates for AMI are highest
in older age groups, this omission may introduce
bias for this study. Also, the estimates from the
HSfE are based on self report, which could under-
estimate true rates.
In the absence of measured epidemiological data, the
DisMod II model can provide estimates of the incidence
of AMI, which may be helpful for health researchers,
health care planners and policy makers. Our research
suggests that estimates for England may be broadly
accurate when applied to the whole population, but can
conceal large inaccuracies when studied by age group.
One reason for this inaccuracy is the ‘steady state’ as-
sumption of DisMod II and as such the model should be
used with caution when estimating the burden of dis-
eases that are changing rapidly within the target
population.
Conclusions
The DisMod II model did not replicate age-specific inci-
dence rates of myocardial infarction observed in the ex-
ternal dataset and therefore did not achieve external
validity.
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